logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (ii) New outpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates13.431.347.146.245.540.337.338.7294645049
Cocaine14.427.336.340.940.943.240.224.2254702422
Stimulants3.45.13.32.62.51.22.25.43352435
Hypnotics and sedatives0.60.70.91.62.75.58.410.81085229
Hallucinogens0.30.40.50.91.52.65.613.4659134
Volatile substances0.50.20.20.10.50.00.80.419926
Cannabis 66.534.611.37.55.75.13.94.8253843588
Other substances 0.80.50.50.41.02.21.72.3575912
Total147903574718744823041742300118110228618812795

Notes:

 Countries reporting data: BE, BG, CZ, DK, DE,EE, IE, EL, ES, FR, IT, CY, LV, HU, MT, NL, AT, RO, SI, SK, FI, SE, HR 

 Last data available from Spain refer to 2007, for Malta refer to 2006 and for Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-106 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 14 July 2010